1. Home
  2. WST vs PHG Comparison

WST vs PHG Comparison

Compare WST & PHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WST
  • PHG
  • Stock Information
  • Founded
  • WST 1923
  • PHG 1891
  • Country
  • WST United States
  • PHG Netherlands
  • Employees
  • WST N/A
  • PHG N/A
  • Industry
  • WST Medical/Dental Instruments
  • PHG Medical Electronics
  • Sector
  • WST Health Care
  • PHG Health Care
  • Exchange
  • WST Nasdaq
  • PHG Nasdaq
  • Market Cap
  • WST 23.2B
  • PHG 24.6B
  • IPO Year
  • WST N/A
  • PHG N/A
  • Fundamental
  • Price
  • WST $332.84
  • PHG $25.74
  • Analyst Decision
  • WST Strong Buy
  • PHG Hold
  • Analyst Count
  • WST 5
  • PHG 4
  • Target Price
  • WST $437.75
  • PHG N/A
  • AVG Volume (30 Days)
  • WST 494.1K
  • PHG 591.8K
  • Earning Date
  • WST 02-13-2025
  • PHG 02-03-2025
  • Dividend Yield
  • WST 0.25%
  • PHG N/A
  • EPS Growth
  • WST N/A
  • PHG N/A
  • EPS
  • WST 6.74
  • PHG N/A
  • Revenue
  • WST $2,876,400,000.00
  • PHG $20,119,339,720.00
  • Revenue This Year
  • WST N/A
  • PHG $3.01
  • Revenue Next Year
  • WST $6.08
  • PHG $4.34
  • P/E Ratio
  • WST $49.37
  • PHG N/A
  • Revenue Growth
  • WST N/A
  • PHG N/A
  • 52 Week Low
  • WST $265.00
  • PHG $19.55
  • 52 Week High
  • WST $413.70
  • PHG $32.91
  • Technical
  • Relative Strength Index (RSI)
  • WST 57.53
  • PHG 40.63
  • Support Level
  • WST $325.33
  • PHG $24.86
  • Resistance Level
  • WST $335.53
  • PHG $25.57
  • Average True Range (ATR)
  • WST 7.57
  • PHG 0.32
  • MACD
  • WST 0.31
  • PHG 0.05
  • Stochastic Oscillator
  • WST 72.40
  • PHG 45.76

About WST West Pharmaceutical Services Inc.

West Pharmaceutical Services is based in Pennsylvania, U.S., and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.

About PHG Koninklijke Philips N.V. NY Registry Shares

Koninklijke Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. Nearly 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, and image-guided therapy solutions. The connected care segment (around 30% of revenue) encompasses monitoring and analytics systems for hospitals, informatics business, and also houses the sleep and respiratory care segment. Personal health business (remainder of revenue) is mainly oral health and personal care product lines, which include electric toothbrushes and men's grooming and personal care products.

Share on Social Networks: